UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Gestational diabetes mellitus screening according to Carpenter–Coustan and IADPSG criteria: A 7-year follow-up of prevalence, treatment and neonatal complications at a Belgian general hospital

Diabetes & metabolism, 2018-06, Vol.44 (3), p.309-312

2018

Volltextzugriff (PDF)

Assessing the incidence of gestational diabetes and neonatal outcomes using the IADPSG guidelines in comparison with the Carpenter and Coustan criteria in a Belgian general hospital

Acta clinica belgica (English ed. Online), 2014, Vol.69 (1), p.8-11

2014

Volltextzugriff (PDF)

P1018 Application systématique et non ciblée des critères de l’IADPSG : quelles conséquences ?

Diabetes & metabolism, 2013-03, Vol.39, p.A36-A36

2013

Volltextzugriff (PDF)

Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery

The New England journal of medicine, 2012-02, Vol.366 (5), p.409-420

2012

Volltextzugriff (PDF)

Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids

The New England journal of medicine, 2012-02, Vol.366 (5), p.421-432

2012

Volltextzugriff (PDF)

Long-term treatment of uterine fibroids with ulipristal acetate

Fertility and sterility, 2014-06, Vol.101 (6), p.1565-1573.e18

2014

Volltextzugriff (PDF)

Intravenous administration of ritodrine to pregnant insulin-dependent diabetics. Metabolic impact

Journal de gynécologie, obstétrique et biologie de la reproduction, 1982, Vol.11 (7), p.869

1982

Volltextzugriff (PDF)

Nonsupplemented Luteal Phase Characteristics after the Administration of Recombinant Human Chorionic Gonadotropin, Recombinant Luteinizing Hormone, or Gonadotropin-Releasing Hormone (GnRH) Agonist to Induce Final Oocyte Maturation in in Vitro Fertilization Patients after Ovarian Stimulation with Recombinant Follicle-Stimulating Hormone and GnRH Antagonist Cotreatment

The journal of clinical endocrinology and metabolism, 2003-09, Vol.88 (9), p.4186-4192

2003

Volltextzugriff (PDF)

Late miscarriage and stillbirth in asymptomatic and symptomatic hospitalised pregnant women in Belgium during the first and second waves of COVID-19: a prospective nationwide population-based study

BMC pregnancy and childbirth, 2023-05, Vol.23 (1), p.356-356, Article 356

2023

Volltextzugriff (PDF)

Recombinant human luteinizing hormone to trigger ovulation: randomized, controlled, dose-finding pilot study in ovulation induction

Journal of reproductive medicine, 2014-07, Vol.59 (7-8), p.355

2014

Volltextzugriff (PDF)

Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment—recombinant HCG versus urinary HCG

Human reproduction (Oxford), 2000-07, Vol.15 (7), p.1446-1451

The European Recombinant Human Chorionic Gonadotrophin Study Group

2000

Volltextzugriff (PDF)

Recombinant follicle stimulating hormone: development of the first biotechnology product for the treatment of infertility

Human reproduction update, 1998-11, Vol.4 (6), p.862-881

Recombinant Human FSH Product Development Group

1998

Volltextzugriff (PDF)

Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women : A dose-finding study

The journal of clinical endocrinology and metabolism, 1998-05, Vol.83 (5), p.1507-1514

Group, T. E. R. H. L. S.

1998

Volltextzugriff (PDF)

Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians

Human reproduction update, 1995-03, Vol.1 (2), p.188-199

1995

Volltextzugriff (PDF)

A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins

Fertility and sterility, 2001-06, Vol.75 (6), p.1131-1135

2001

Volltextzugriff (PDF)

Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization

Fertility and sterility, 1995-01, Vol.63 (1), p.77-86

Recombinant Human FSH Study Group

1995

Volltextzugriff (PDF)

Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?

Human reproduction (Oxford), 1999-08, Vol.14 (8), p.1939-1943

1999

Volltextzugriff (PDF)

The population pharmacokinetics of recombinant‐ and urinary‐human follicle stimulating hormone in women

British journal of clinical pharmacology, 1998-01, Vol.45 (1), p.13-20

1998

Volltextzugriff (PDF)

Molecular interactions between embryo and uterus in the adhesion phase of human implantation

Human reproduction (Oxford), 1998-06, Vol.13 (suppl-3), p.219-232

1998

Volltextzugriff (PDF)

Successful induction of fertility in a hypogonadotropic male

The Lancet (British edition), 1994-03, Vol.343 (8899), p.733-733

1994

Volltextzugriff (PDF)

A population model for the follicular growth in women treated with follicle stimulating hormone

Clinical pharmacology and therapeutics, 1997-12, Vol.62 (6), p.665-674

1997

Volltextzugriff (PDF)

Efficacy of Recombinant Follicle-Stimulating Hormone

Fertility and sterility, 1996-07, Vol.66 (1), p.164-164

1996

Volltextzugriff (PDF)

Discussion: molecular interactions between embryo and uterus

Human reproduction (Oxford), 1998-06, Vol.13 (suppl-3), p.233-236

1998

Volltextzugriff (PDF)

Endocrinology. Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?

Human reproduction (Oxford), 1999-08, Vol.14 (8), p.1939

1999

Volltextzugriff (PDF)

Treatment of severe male infertility with pure follicle-stimulating hormone (FSH): the need for a properly controlled multicentre trial

Human reproduction (Oxford), 1993-03, Vol.8 (3), p.500-501

1993

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(22)
Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Female
(18)
Adult
(17)
Obstetrics & Gynecology
(12)
Biological And Medical Sciences
(10)
Reproductive Biology
(10)
Medical Sciences
(9)
Pregnancy
(8)
Fertilization In Vitro
(7)
Follicle Stimulating Hormone - Therapeutic Use
(6)
Pharmacology. Drug Treatments
(6)
Endocrinology & Metabolism
(5)
Double-Blind Method
(4)
General & Internal Medicine
(4)
Gynecology. Andrology. Obstetrics
(4)
Hormones. Endocrine System
(4)
Ivf
(4)
Male
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gestational diabetes mellitus screening according to Carpenter–Coustan and IADPSG criteria: A 7-year follow-up of prevalence, treatment and neonatal complications at a Belgian general hospital

Assessing the incidence of gestational diabetes and neonatal outcomes using the IADPSG guidelines in comparison with the Carpenter and Coustan criteria in a Belgian general hospital

P1018 Application systématique et non ciblée des critères de l’IADPSG : quelles conséquences ?

Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery

Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids

Long-term treatment of uterine fibroids with ulipristal acetate

Intravenous administration of ritodrine to pregnant insulin-dependent diabetics. Metabolic impact

Late miscarriage and stillbirth in asymptomatic and symptomatic hospitalised pregnant women in Belgium during the first and second waves of COVID-19: a prospective nationwide population-based study

Recombinant human luteinizing hormone to trigger ovulation: randomized, controlled, dose-finding pilot study in ovulation induction

Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment—recombinant HCG versus urinary HCG

Recombinant follicle stimulating hormone: development of the first biotechnology product for the treatment of infertility

Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women : A dose-finding study

Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians

A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins

Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization

Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?

The population pharmacokinetics of recombinant‐ and urinary‐human follicle stimulating hormone in women

Molecular interactions between embryo and uterus in the adhesion phase of human implantation

Successful induction of fertility in a hypogonadotropic male

A population model for the follicular growth in women treated with follicle stimulating hormone

Efficacy of Recombinant Follicle-Stimulating Hormone

Discussion: molecular interactions between embryo and uterus

Endocrinology. Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?

Treatment of severe male infertility with pure follicle-stimulating hormone (FSH): the need for a properly controlled multicentre trial

Suchergebnisse filtern